Vimian Group
41
SEK
-7,03 %
Mindre end 1K følgere
VIMIAN
NASDAQ Stockholm
Health Care Providers
Health Care
Overview
Ownership
Investor consensus
-7,03%
+1,61%
+1,99%
+3,02%
-9,39%
+25,57%
-27,62%
-
-47,66%
Vimian Group is a group active in animal health. Through its subsidiaries, the company delivers medicines and technical solutions to veterinarians, laboratories, and pet owners. The products include, for example, drugs with associated clinical research and digital platforms for veterinary clinics. The company operates worldwide and is headquartered in Stockholm.
Læs mereMarkedsværdi
21,48 mia. SEK
Aktieomsætning
26,32 mio. SEK
Omsætning
4,3 mia.
EBIT %
13,13 %
P/E
89,37
Udbytteafkast, %
-
Finanskalender
29.4
2025
Generalforsamling '25
29.4
2025
Delårsrapport Q1'25
18.7
2025
Delårsrapport Q2'25
Alle
Selskabspræsentationer
Selskabsmeddelelser
ViserAlle indholdstyper
Trading in Vimian Group AB (publ)’s ordinary shares on Nasdaq Stockholm commences today
Vimian Group AB (publ) publishes prospectus in connection with its listing on Nasdaq Stockholm’s Main Market
Join Inderes community
Don't miss out - create an account and get all the possible benefits
Inderes account
Followings and notifications on followed companies
Analyst comments and recommendations
Stock comparison tool & other popular tools
Vimian’s Nomination Committee proposes Pia Marions as new Board member
Vimian has been approved for listing on Nasdaq Stockholm
Vimian publishes Annual Report and Sustainability Report for 2024

Vimian Group, Audiocast with teleconference, Year-end Report, 2024
Vimian’s year-end report for 2024
Invitation to Vimian’s year-end report for 2024

Vimian Group, Audiocast with teleconference, Q3'24
Vimian’s Interim Report for the third quarter of 2024
Invitation to Vimian’s Interim Report for the third quarter of 2024
Nomination Committee for Vimian’s 2025 Annual General Meeting
Vimian Group to enter new MedTech niche through the acquisition of a global veterinary dental company
